news

Please send us news about clean-technology companies, trends, and industry events. All materials are subject to editorial review. E-mail us at editor@cleanedge.com.

 
 

indexes

Clean Edge Stock Indexes: Tracking the Performance of U.S.-Traded Clean-Energy and Global Wind and Smart Grid Infrastructure Companies.

Subscribe to Clean Edge RSS
Search News:
[icon: Print]Print Bookmark and Share

Previous Story | Next Story

Q-Cells Slashes 500 Jobs as Part of 'Adjustment' Process

August 14, 2009
Source: Clean Edge News

Q-Cells has announced a set of adjustment measures, including workforce reduction by almost 20%, following losses in H1 2009.

Q-Cells has posted a 37.8% fall in sales in H1 2009, compared with the same period in 2008 and an operating loss of 47.6 million euros ($68 million). In reaction to the losses, Q-Cells will apply a set of measures called "Q-Cells Reloaded", in order to adjust to the new environment. Crucially, the company decided to cut almost 20% of its workforce and close production lines in Thalheim.

Q-Cells said that the cost structure of Thalheim production lines lies "around 30% above the usually accepted level in international competition" and therefore the board decided to shut them down. As a result, "around 500 jobs will be cut permanently", resulting in a reduction of a production cost of 25%.

Further measures include focusing on R&D in cells efficiency, mainly through companies Silbro and Calyxo, where Q-Cells holds controlling stakes. Q-Cells plans to achieve 20% efficiency by the end of 2011 and further expand these companies in the future.

Finally, the company also said that in order to reinforce its in-house financing, all investment projects and especially those for 2010, would be reviewed and capital commitment reduced.

"To steer Q-Cells safely through the crisis and give the company a long-term perspective at the Thalheim location, these measures including a cut in personnel are unavoidable," concluded Anton Milner, chairman of Q-Cells executive board.

Shares in Q-Cells fell almost 6% on the day of announcement and were trading at 13.35 euros on Thursday afternoon.